Colorado Springs, COLORADO3 Active Studies

Spinal Muscular Atrophy Clinical Trials in Colorado Springs, COLORADO

Find 3 actively recruiting spinal muscular atrophy clinical trials in Colorado Springs, COLORADO. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
1,868
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Colorado Springs

About Spinal Muscular Atrophy Clinical Trials in Colorado Springs

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 3 spinal muscular atrophy clinical trials recruiting participants in Colorado Springs, COLORADO. These studies are seeking a combined 1,868 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Colorado Springs — FAQ

Are there spinal muscular atrophy clinical trials in Colorado Springs?

Yes, there are 3 spinal muscular atrophy clinical trials currently recruiting in Colorado Springs, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 3 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov